Antibodies to Biotherapeutics

Supporting biosimilar development, preclinical and clinical research

Antibodies to Biotherapeutics

Our anti-biotherapeutic monoclonal antibodies are ideal for your biosimilar development and validation process.

  • Time Saving: immediate source of ready-made, highly affinity antibodies
  • Validated: supported with detailed data for PK, IR and inhibition assays
  • Highly Sensitive: sensitivity in low ng/mL range
  • Flexible: Fab or full immunoglobulin antibodies with three different binding modes
  • Reliable:  recombinant, giving a secure and batch-to-batch consistent supply

Ready-made Anti-Biotherapeutic Antibodies

 


Can't find your biologic on our current list?

Influence our product development - make your preferred antibody our priority.

Please tick the antibody drugs you are interested in, and let us know if you would like to be informed when the anti-drug antibodies are available.

Etanercept                       Enbrel®
Abciximab                        ReoPro®
Denosumab                     Prolia®, Xgeva®
Ofatumumab                   Arzerra®, HuMax-CD20
Eculizumab                      Soliris®
Certolizumab pegol       Cimzia®
Ranibizumab                   Lucentis®
Abatacept                       Orencia®
Ipilimumab                       Yervoy®
Nivolumab                       Opdivo®
Pembrolizumab               Keytruda®
Pertuzumab                     Perjeta®
Vedolizumab                   Entyvio®
Other
Notify me when new antibodies are available.
Do you know we can develop the anti-idiotypic antibodies specific to your biotherapeutics? Please find out more about our Custom Anti-Drug Antibodies
 

 


ACTEMRA® is a registered trademark of Chugai Seiyaku Kabushiki Kaisha Corp., a member of the Roche Group.Tysabri® is a registered trademark of Elan Pharmaceuticals, Inc. Enbrel® is a registered trademark of Amgen Inc. Vectibix® is a registered trademark of Amgen. Synagis® is a registered trademark of MedImmune, LLC. REOPRO® is a trademark of Eli Lilly and Company. Prolia® is a trademark of Amgen Inc. ARZERRA® is a registered trademark of the GlaxoSmithKline group of companies. Soliris® is a trademark of Alexion Pharmaceuticals. CIMZIA® is a trademark of the UCB Group of Companies. Lucentis is a registered trademark of Genentech Inc.